GET VISIBLY FACE LIFTED WITH SKINCEUTICALS' NEWEST LIFTING SOLUTION A.G.E. INTERRUPTER ULTRA SERUM

With Sagging Skin the No. 4 Condition for Dermatology Patients, This Double-Patented, Clinically Proven Serum is the Solution: It Lifts and Tightens For a More Visibly Sculpted Appearance

NEW YORK, Aug. 4, 2025 /PRNewswire/ -- SkinCeuticals, the #1 Medical Aesthetic Skincare Brand Worldwide*, announces the launch of A.G.E. Interrupter Ultra Serum, the latest science-backed product in its A.G.E. line. Sagging skin is a top concern driving patients to dermatologists, and this serum debuts as a response to one of the most visible side effects of modern wellness: changes in skin appearance, like skin laxity, which can be amplified by rapid weight loss. A.G.E. Interrupter Ultra Serum is a solution for individuals looking for non-invasive treatments or an adjunct to in-office procedures to address sagging skin. Clinically proven to deliver visible skin lifting of up to +18%¹, A.G.E Interrupter Ultra Serum tightens 4 key areas from the face to the neck. For patients using an integrated skincare approach, pairing the A.G.E. Serum and Cream with an ultrasound procedure delivers -20% skin laxity vs. control in 12 weeks and is physician-tested with GLP-1 patients.

"I've seen a marked increase in patients experiencing skin laxity, and they are looking for effective, non-invasive solutions for their sagging skin," says Dr. Julie Woodward, Oculofacial Plastic Surgeon. "A.G.E. Interrupter Ultra Serum is incredibly effective and clinically proven to deliver visible lifting and tightening results on its own. When paired with existing SkinCeuticals product A.G.E. Interrupter Advanced Cream and an ultrasound procedure, patients can expect visible improvements to their skin laxity. This makes a huge difference in these patients' lives, giving them tools that help them achieve as much confidence in their face as they have in their body. This serum is truly a 'visible lift in a bottle'."

Designed to deliver powerful lifting results, A.G.E. Interrupter Ultra Serum effectively addresses visible signs of aging linked to collagen loss and glycation. It is engineered with double-patented technology and formulated with a potent 34.6% concentration of Flavo-Proxylane™, Rhamnose, and Gentiana Lutea Root Extract. This serum formula with optimized level of emollients, polymers, and patent-pending film formers has a lightweight and non-sticky feel for a velvety-smooth finish.

"At L'Oréal, we are dedicated to transforming cutting-edge science into effective beauty solutions," said Qian Zheng, Senior Vice President of Advanced Research and Global Head of Regenerative Beauty at L'Oréal Groupe. "SkinCeuticals' A.G.E. Interrupter Ultra Serum stands out by addressing the signs of aging caused by glycation and collagen degradation."

Clinically Proven Results:

In a U.S. clinical study¹ on all skin tones, the A.G.E. Interrupter Ultra Serum demonstrated powerful, visible improvements across multiple key indicators of aging. The serum visibly lifts skin by up to 18%, reduces wrinkles by up to 16%, and improves skin smoothness by up to 54% in 12 weeks. A.G.E. Interrupter Ultra Serum is formulated to complement lifting ultrasound procedures and proven to work synergistically within regimens that include A.G.E. Interrupter Advanced Cream, including use among GLP-1 patients. New breakthrough clinical testing² shows when A.G.E. regimen is paired with ultrasound on GLP-1 patients, it visibly reduces skin laxity by -20%.

¹Clinical testing of 76 non-GLP-1 subjects after 12 weeks showed up to: +18% visible lifting, -16% global wrinkles, and +54% smoothness and average results of +7.6% lifting, -7.6% global wrinkles, and +40% smoothness improvement across all 76 subjects. Shown in testing to be well tolerated by GLP-1 users. Results shown here were not tested on GLP-1 users..

²A 12-week, double-blind, randomized, controlled, split-face and split-neck clinical study investigated the effects of a flavo-proxylane regimen compared to a control regimen on 25 patients, who were also undergoing GLP-1 treatments. The study assessed skin quality, aging signs and treatment tolerance at multiple time points before and after a single ultrasound treatment.

Key Ingredients & Usage:

The A.G.E. Interrupter Ultra Serum is formulated with a potent blend of key ingredients designed to visibly lift, tighten and resculpt the skin. At the core is 34.6% Flavo-Proxylane™, including 30% Proxylane™, which helps support the skin's structure to visibly re-tighten and lift. 4.6% Wild Fruit Flavonoids, including blueberry, pomegranate, and new Cassia Alata Extract, work synergistically to reduce oxidative stress and protect against free radical damage. Rhamnose, a hydrating and anti-aging ingredient, helps improve skin firmness and elasticity, while Gentiana Lutea Root Extract helps contribute to a more sculpted and contoured appearance across the face and neck. For best results, the serum should be applied twice daily—morning and evening—on clean skin, including before and after lifting ultrasound procedures.

Availability & Pricing:

A waitlist for A.G.E. Interrupter Ultra Serum will launch on www.skinceuticals.com July 26, and the product will be available on August 4, 2025 at www.skinceuticals.com, as well as at partner skincare professionals nationwide near you (find yours at skinceuticals.com/locate).

Price: $185

About SkinCeuticals
SkinCeuticals founding scientist, Dr. Sheldon Pinnell changed the face of topical antioxidants with his pivotal research at Duke University. Founded in Dallas, TX in 1997, SkinCeuticals discovers, develops and delivers an advanced line of scientifically backed products with an integrated skincare approach. SkinCeuticals is backed by 20 integrated skincare studies. Its products have been proven to complement the outcomes of in-office procedures and help minimize downtime. The brand is dispensed by over 10,500 international dermatologists, plastic surgeons, and medi-spas worldwide. For more information, visit skinceuticals.com. 

For imagery or press inquiries, please contact:
Nicole Kaldes at SkinCeuticals, [email protected]; or [email protected]

SOURCE SkinCeuticals